|
|
News Breaks | | | | November 16, 2012 | | 06:34 EDT |  | MYGN | Myriad Genetics coverage resumed with a Market Perform at JMP Securities
| |
|
News For MYGN From The Last 14 Days Check below for free stories on MYGN the last two weeks. |
|
|
| June 17, 2013 | | 09:19 EDT |  | MYGN | On The Fly: Pre-market Movers
 Subscribe for More Information | | | 07:07 EDT | | MYGN | DaVita, Myriad RMB announces biomarker research collaboration
Subscribe for More Information | | | 05:49 EDT |  | MYGN | Stocks with implied volatility movement; MYGN CLWR
Stocks with implied volatility movement; Myriad Genetics (MYGN), Clearwire (CLWR) according to IVolatility. | | | June 14, 2013 | | 16:34 EDT |  | MYGN | On The Fly: Closing Wrap
Stocks on Wall Street were lower after opening higher, but pulling back from its early levels following consumer confidence data that pulled back from recent six-year highs. The averages moved to their worst levels near mid-afternoon and closed off those levels, with the Dow logging the day's biggest losses. ECONOMIC EVENTS: In the U.S., the producer price index for May rose 0.5% from the prior month, versus expectations for a 0.1% month-over-month increase. Core PPI, which excludes the food and energy components, increased 0.1%, matching forecasts. The first quarter current account balance showed the deficit shrunk to $106.1B, versus consensus for the current account deficit to widen to $111.2B. May industrial production was flat, compared to expectations for it to grow 0.2%, while capacity utilization fell to 77.6% from the revised prior reading of 77.7%. The preliminary Reuters/University of Michigan consumer sentiment reading for June slipped to 82.7 from the prior 84.5 reading, where it had been forecast to hold steady. In Europe, employment in the euro zone currency bloc shrank 0.5% in the first three months of the year from the prior quarter, while the wider EU saw a 0.2% decline. EU consumer prices rose by 0.1% in May, putting the annual inflation rate at 1.4% compared to 1.2% in April, Eurostat said. COMPANY NEWS: Elan (ELN) shares gained $1.05, or 8.33%, to $13.66 after the company said it will explore a possible sale of the company "in light of the expressions of interest received to date." Royalty Pharma, which has been making a hostile takeover bid for the Irish drugmaker, was invited to participate in the process... Walter Energy (WLT) fell $2.56, or 17.43%, to $12.13 after a report by Forbes said the company withdrew a proposed $1.55B loan refinancing. The company later released a statement saying the proposed refinancing would not have raised additional capital and that the company has no material debt principal payments due until 2015. MAJOR MOVERS: Among the notable gainers was Restoration Hardware (RH), up $9.51, or 16.13%, to $68.47 after its quarterly results beat expectations and the company raised its fiscal year outlook. Also higher were shares of Charter Communications (CHTR), up $5.72, or 5.16%, to $116.61, and Time Warner Cable (TWC), up $7.78, or 8.09%, to $103.93 after CNBC's David Faber reported Liberty Media's (LMCA) CEO discussed a combination between Charter and Time Warner with Time Warner Cable's CEO. Among the noteworthy losers was Myriad Genetics (MYGN), down another $4.42, or 13.81%, or $27.59 the day after the Supreme Court ruled on gene patents. INDICES: The Dow was down 105.90, or 0.70%, to 15,070.18; the S&P was down 9.63, or 0.59%, to 1,626.73; the Nasdaq was down 21.81, or 0.63%, to 3,423.56. | | | 14:38 EDT | | MYGN | Market poised to end week lower amid worries about Fed, Asia
Subscribe for More Information | | | 12:43 EDT | | MYGN | On The Fly: Midday Wrap
Subscribe for More Information | | | 11:07 EDT |  | MYGN | Myriad likely to see little impact from competition, says Piper Jaffray
Subscribe for More Information | | | 10:52 EDT | | MYGN | High option volume stocks: CLDX AON KNDI MYGN SPLS
| | | 10:10 EDT |  | MYGN | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Express (AXP) downgraded to Equal Weight from Overweight at Barclays... AngloGold (AU) downgraded to Sell from Neutral at UBS... DuPont (DD) downgraded to Neutral from Buy at BofA/Merrill... Myriad Genetics (MYGN) downgraded to Neutral from Buy at BofA/Merrill... Progress Software (PRGS) downgraded to Hold from Buy at Needham... Rubicon (RBCN) downgraded to Sell from Neutral at Goldman... Southern Company (SO) downgraded to Hold from Buy at Jefferies... SunTrust (STI) downgraded to Neutral from Buy at UBS... Wells Fargo (WFC) downgraded to Neutral from Buy at Sterne Agee... FIS (FIS) downgraded to Neutral from Outperform at RW Baird... SM Energy (SM) downgraded to Hold from Buy at Societe Generale..Wells Fargo (WFC) downgraded at Sterne Agee. | | | 10:10 EDT |  | MYGN | On The Fly: Analyst Upgrade Summary
Subscribe for More Information | | | | 09:59 EDT |  | MYGN | Myriad Genetics gaps down, spikes lower, levels to watch
The stock is down over 10.3% to $28.69 this morning. A report in the New York Times noted that the company has effectively lost its monopoly for genetic testing to indicate breast cancer risk with the SCOTUS decision that human genes cannot be patented. Several competitors have announced that they will begin creating generic tests in the wake of the ruling. At the current price of $28.69, next support is at $28.28. Resistance is at $29.80, the 50-day moving average. | | | 09:24 EDT | | MYGN | On The Fly: Pre-market Movers
HIGHER: Groupon (GRPN), up 8% following upgrade at Deutsche Bank... SolarCity (SCTY), up 8% following upgraded to Outperform from Neutral at Credit Suisse... Smith & Wesson (SWHC), up 5.4% after earnings pre-announcement, share buyback plan... Elan (ELN), up 7.7% after starting formal sale process. UP AFTER EARNINGS: Restoration Hardware (RH), up 12.5%. LOWER: China Ming Yang Wind Power (MY), down 4% after CFO steps down... Myriad Genetics (MYGN), down another 4.9% after Supreme Court ruling yesterday on gene patents... News Corp. (NWSA), down 1.5% after CFO announces plan to retire following split. | | | 08:19 EDT | | MYGN | Myriad Genetics IP still strong, says Cantor
After the Supreme Court upheld some of Myriad's patent claims and overturned others, Cantor believes that the company's intellectual property around BRACAnalysis remains strong through 2018. The firm expects the company to aggressively defend its IP going forward, and it reiterates a Buy rating on the stock. | | | 06:47 EDT | | MYGN | Myriad Genetics upgraded to Outperform from Market Perform at JMP Securities
JMP Securities upgraded Myriad citing valuation and said the Supreme Court decision removes an overhang. | | | 06:40 EDT |  | MYGN | Myriad Genetics loses monopoly, NY Times reports
Subscribe for More Information | | | 06:36 EDT | | MYGN | Myriad Genetics downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Myriad Genetics following the Supreme Court's ruling on gene patents. | | | 06:35 EDT | | MYGN | Myriad Genetics downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information | | | June 13, 2013 | | 17:23 EDT | | MYGN | Quest Diagnostics to offer cancer tests, DJ reports
Subscribe for More Information | | | 16:25 EDT | | MYGN | On The Fly: Closing Wrap
Subscribe for More Information | | | 14:21 EDT | | MYGN | Follow-up: Myriad Genetics downgraded to Market Perform at Leerink
Subscribe for More Information | | |
|
|
|
|
|
|
